Article Text

Download PDFPDF
Letters to the editor
First UK data for CT angiography in persisting upper GI bleeding
  1. Suneil A Raju1,
  2. Peter D Mooney1,
  3. Karuna Kodali1,
  4. Charmaine Toh1,
  5. Daniel Kusumawidjaja2,
  6. Naomi Hersey3,
  7. Hugo Penny1,
  8. Matthew Kurien1,
  9. David S Sanders1
  1. 1 Department of Infection and Immunity and Cardiovascular Science, Academic Unit of Gastroenterology, The University of Sheffield, Sheffield, UK
  2. 2 Sheffield Vascular Institute, Northern General Hospital, Sheffield, UK
  3. 3 Department of Radiology, Northern General Hospital, Sheffield, UK
  1. Correspondence to Dr Suneil A Raju, Gastroenterology and Liver Unit, Royal Hallamshire Hospital, Sheffield, S10 2JF, UK; suneilraju{at}gmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read with interest the study by S Kumar et al that noted that patients with new gastrointestinal (GI) bleeding during admission to the intensive care unit (ICU) were more likely to die during hospitalisation.1 GI bleeding cannot always be controlled or identified at gastroscopy; therefore, guidelines recommend radiological intervention.2 3 Radiological intervention may be of value in uncontrolled GI bleeding where a lesion has already been identified at endoscopy or if no lesion has been detected endoscopically but the patient continues to be haemodynamically unstable. Fluoroscopic angiography (FA) is time consuming, requires significant expertise and has significant ionising radiation exposure. However, the recent advent of CT angiography (CTA) potentially offers a sensitive, rapid and accurate diagnosis of the source of persisting GI bleeding and has a lesser risk of vessel dissection or damage than catheter angiography. For these …

View Full Text

Footnotes

  • Contributors DSS conceptualised and designed the study. PDM, KK, CT, NH, MK and HP recruited patients for the study. SAR and DSS drafted the article. All authors approved the final article, analysed and interpreted the data.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Not required.

  • Ethics approval Sheffield Teaching Hospitals Clinical Effectiveness Unit.

  • Provenance and peer review Not commissioned; externally peer reviewed.